Back to Search
Start Over
Single nucleotide polymorphism in ABCG2 is associated with irinotecan-induced severe myelosuppression
- Source :
- Journal of human genetics. 54(10)
- Publication Year :
- 2009
-
Abstract
- Irinotecan is an anti-neoplastic agent that is widely used for treating colorectal and lung cancers, but often causes toxicities such as severe myelosuppression and diarrhea. In this study, we performed a two-stage case-control association study for irinotecan-induced severe myelosuppression (grades 3 and 4). In the first stage, 23 patients who developed severe myelosuppression and 58 patients who did not develop any toxicity were examined for 170 single nucleotide polymorphisms (SNPs) in 14 genes involved in the metabolism and transport of irinotecan. A total of five SNPs were identified to show the possible association with severe myelosuppression (P(Fisher)
- Subjects :
- Adult
Male
medicine.medical_specialty
Single-nucleotide polymorphism
Bone Marrow Cells
Pharmacology
Irinotecan
Gastroenterology
Models, Biological
Polymorphism, Single Nucleotide
Internal medicine
Neoplasms
Genetics
medicine
Immune Tolerance
SNP
ATP Binding Cassette Transporter, Subfamily G, Member 2
Humans
Genetics (clinical)
Aged
Retrospective Studies
Aged, 80 and over
business.industry
Case-control study
Retrospective cohort study
Middle Aged
medicine.disease
Antineoplastic Agents, Phytogenic
Neoplasm Proteins
Diarrhea
Case-Control Studies
Toxicity
ATP-Binding Cassette Transporters
Camptothecin
Female
medicine.symptom
business
Adverse drug reaction
medicine.drug
Subjects
Details
- ISSN :
- 1435232X
- Volume :
- 54
- Issue :
- 10
- Database :
- OpenAIRE
- Journal :
- Journal of human genetics
- Accession number :
- edsair.doi.dedup.....94d65d68ed71b502e0807ea52e5a09bf